2-[(3-Fluorophenyl)methyl]pyrrolidine | 1016499-34-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[(3-Fluorophenyl)methyl]pyrrolidine
• CAS: 1016499-34-5
• 化学式: C₁₁H₁₄FN
• mdl: MFCD09804749
• 分子量: 179.237
• InChiKey: MRXGOHHNQHZIDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-[(3-Fluorophenyl)methyl]pyrrolidine 、 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙腈 为溶剂， 反应 4.0h， 生成 C₂₁H₂₅FN₂O₂
  参考文献：
  名称：

  Bis(2,2,2-trifluoroethyl) Carbonate as a Condensing Agent in One-Pot Parallel Synthesis of Unsymmetrical Aliphatic Ureas

  摘要：

  One-pot parallel synthesis of unsymmetrical aliphatic ureas was achieved with bis(2,2,2-trifluoroethyl) carbonate. The procedure worked well for both the monosubstituted and functionalized alkyl amines and required no special conditions (temperature control, order, or rate of addition). A library of 96 diverse ureas was easily synthesized.

  DOI：

  10.1021/co500025f

文献信息

• [EN] BETA-HYDROXY HETEROCYCLIC AMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA<br/>[FR] AMINES HÉTÉROCYCLIQUES BÊTA-HYDROXY ET LEUR UTILISATION DANS LE TRAITEMENT DE L'HYPERGLYCÉMIE
  申请人：ATROGI AB

  公开号：WO2019053425A1

  公开（公告）日：2019-03-21

  There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1, ring A, m and n have meanings as provided in the description.

  在此提供了一个式子(I)的化合物或其药用可接受的盐，其中X、R1、环A、m和n的含义如描述中所提供。
• HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT
  申请人：Voronoi Inc.

  公开号：EP3943491A1

  公开（公告）日：2022-01-26

  The present invention relates to a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative, and a pharmaceutical composition for preventing or treating cancer comprising the compound as an effective component. The compound exhibits high inhibitory activity against an epidermal growth factor receptor (EGFR) variant, or wild-type or variants of one or more of ERBB2 and ERBB4, and thus may be usefully used in the treatment of cancers in which same are expressed. In particular, the compound exhibits excellent inhibitory activity on proliferation of lung cancer cell lines, and can thus be usefully used in the treatment of lung cancer.

  本发明涉及一种 6-(异噁唑烷-2-基)-N-苯基嘧啶-4-胺衍生物，以及一种预防或治疗癌症的药物组合物，其中包含该化合物作为有效成分。该化合物对表皮生长因子受体（EGFR）变体、野生型或 ERBB2 和 ERBB4 中一种或多种的变体具有很高的抑制活性，因此可用于治疗表达这些变体的癌症。特别是，该化合物对肺癌细胞株的增殖具有极佳的抑制活性，因此可用于治疗肺癌。
• [EN] HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT<br/>[FR] DÉRIVÉ HÉTÉROARYLE, SON PROCÉDÉ DE PRODUCTION ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT EN TANT QUE CONSTITUANT EFFICACE<br/>[KO] 헤테로아릴 유도체, 이를 제조하는 방법, 및 이를 유효성분으로 포함하는 약학적 조성물
  申请人：VORONOI CO LTD

  公开号：WO2020190119A1

  公开（公告）日：2020-09-24

  6-(아이소옥사졸리딘-2-일)-N-페닐피리미딘-4-아민 유도체, 상기 화합물을 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물에 관한 것이고, 상기 화합물은 EGFR(epidermal growth factor receptor) 돌연변이, 또는 ERBB2 및 ERBB4 중 하나 이상의 야생형 또는 돌연변이에 대하여 높은 억제능을 나타내므로, 이들이 발현된 암의 치료에 유용하게 사용될 수 있으며, 특히, 폐암 세포주 증식 억제능이 우수한 바, 폐암의 치료에 유용하게 사용될 수 있다.
• Bis(2,2,2-trifluoroethyl) Carbonate as a Condensing Agent in One-Pot Parallel Synthesis of Unsymmetrical Aliphatic Ureas
  作者：Andrey V. Bogolubsky、Yurii S. Moroz、Pavel K. Mykhailiuk、Dmitry S. Granat、Sergey E. Pipko、Anzhelika I. Konovets、Roman Doroschuk、Andrey Tolmachev

  DOI：10.1021/co500025f

  日期：2014.6.9

  One-pot parallel synthesis of unsymmetrical aliphatic ureas was achieved with bis(2,2,2-trifluoroethyl) carbonate. The procedure worked well for both the monosubstituted and functionalized alkyl amines and required no special conditions (temperature control, order, or rate of addition). A library of 96 diverse ureas was easily synthesized.